Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating, two have given a buy rating and one has given
FrontView REIT (NYSE: FVR - Get Free Report) and Global Medical REIT (NYSE: GMRE - Get Free Report) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Valuation and Earnings This table compares
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief F.
Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that the Company will change its name, effective as of 12:01 a.m., Eastern Time, on February 23, 2026, to “Chiron Real Estate Inc.” Beginning on February 23, 2026, the Company's common stock will trade on the New York Stock Exchange (the “NYSE”) under the new name, “Chiron Real Estate Inc.,” and ticker symbol “XRN.” “After spending the last six months evaluating and redefining our str.
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that information regarding the federal income tax treatment of the dividends paid in 2025 on the Company's Common Stock and Series A Preferred Stock has been posted to the Company's website, at the following link. https://investors.globalmedicalreit.com/stock-data/dividend-tax-information Note: Data for common dividends paid in January, April and July 2025 have been adjusted to refle.
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Henry Cole has notified the Board of Directors (the “Board”) that he plans to step down as a member of the Board at the end of his current term. Henry Cole's Stepping Down from Board of Directors Mr. Cole has served on the Board as an Independent Director since the Company's inception and has served at different points throughout his term as the Board's Lead Independent Director,.
Cascade Investment Group Inc. decreased its position in shares of Global Medical REIT Inc. (NYSE: GMRE) by 80.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,749 shares of the company's stock after selling 30,996 shares during the period.
Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, three have given a buy rating and
Global Medical REIT (NYSE: GMRE - Get Free Report) and Global Self Storage (NASDAQ: SELF - Get Free Report) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Analyst Recommendations This is a
Global Medical REIT offers a diversified, granular healthcare property portfolio with 95.2% occupancy and an average remaining lease term of 5.3 years. GMRE has proactively extended and staggered its debt maturities, raised $50M in Series B preferred equity, and improved balance sheet flexibility. The Series A Preferred Shares yield 7.7%, are past call, and are unlikely to be redeemed soon given current rates and refinancing costs.
Global Medical REIT offers a compelling value proposition, with an 8.9% dividend yield and a forward P/FFO of 8.3. GMRE's diversified healthcare portfolio, 95%+ occupancy, and 2.1% annual rent escalators support steady cash flows and modest growth. Management's proactive debt restructuring extends maturities, mitigating refinancing risk.
Active investors have an advantage in the REIT sector. Individual REITs often get mispriced, resulting in opportunities to earn alpha-rich returns. We highlight a clear example of that.
Armada Hoffler, Easterly Government Properties, and Global Medical REIT trade at deep NAV discounts and low FFO multiples after dividend cuts. AHH, DEA, and GMRE offer 8.5%–9% yields and 60%–125% potential capital appreciation if multiples revert to REIT averages. Tax-loss selling and AI-driven market rotation have intensified REIT discounts, creating unusually attractive entry points for value-focused investors.
Global Medical REIT is rated a buy, driven by strong AFFO growth, robust dividend coverage, and sector tailwinds. GMRE redeploys capital into higher cap-rate assets, maintains low tenant concentration risk, and benefits from geographic diversification including presence in high-growth regions like Texas and Florida. Despite elevated leverage (D/E 1.50), GMRE's forward P/FFO of 8.6 is 35% below sector average, suggesting undervaluation.
We are in the midst of the biggest retail sales period of the year. Yet, investors are skeptical about bargains in the stock market. Buy a bigger income stream at cheaper prices. We discuss our top defensive picks with up to 8% yields.
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company's 2025 fourth quarter common and preferred dividends. Ronald Marston's Retirement from Board of Directors Mr. Marston has served on the Board since 2015 as an independent director and at differ.
Global Medical REIT Inc. has launched its 8.00% Series B Cumulative Redeemable Preferred Stock GMRE.PR.B, targeting high-yield seeking investors. GMRE-B offers a high yield but is considered highly speculative, with no credit rating and a risk profile similar to Single-B rated debt. Recent red flags for GMRE include a reverse stock split, a dividend cut, and a debt-heavy capital structure, warranting extra caution for investors.
Shares of Global Medical REIT Inc. (NYSE: GMRE - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven research firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, three have given a buy
I invest most of my capital in REITs. Even then, I'm bearish on a lot of them. This is a sector in which you need to be very selective to succeed.